Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Drug Development

Mitochondrion in cell cross section
Blog Post

Simply Stated: Research Updates in Leigh Syndrome

By Sujatha Gurunathan | December 6, 2023
Graphic of the inside of a human cell
Featured Article

Q&A: Understanding Metabolic Myopathies

By MDA Staff | November 17, 2023
Blog Post

Clinical Trial Alert: Phase 3 Study of Brepocitinib in Adults with Dermatomyositis

By Sujatha Gurunathan | November 16, 2023
Blog Post

AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy

By MDA Staff | October 26, 2023
Blog Post

Clinical Trial Alert: Phase 3 Study of Batoclimab in Adults with MG

By Sujatha Gurunathan | September 29, 2023
Blog Post

New Therapy Brings Hope for Late-Onset Pompe Disease

By Melissa Donahue | September 21, 2023
Blog Post

Deconstructing SMA Types and Treatments

By Sujatha Gurunathan | August 23, 2023
Blog Post

FDA Approves Sarepta’s ELEVIDYS for Treatment of DMD

By Sujatha Gurunathan | June 22, 2023
Featured Article

Gene Therapy Options Grow With New Drug Approvals

By Larry Luxner | May 18, 2023
Featured Article

How MDA Invests in Research Success

By Maggie Callahan | May 18, 2023
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 17
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset